PHOTOPHARMICA
Photopharmica is discovers and develops photo sensitizers and light sources for medical use in the United Kingdom. It develops anti-infective agents primarily for dermatology and wound management markets; and medical devices in the fields of orthopedics and periodontal equipment. Its products pipeline includes phenothiazinium photo sensitizers for use as topical therapeutic antimicrobial agents; phenothiazinium photo sensitizers for systemic oncology use; and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization.
PHOTOPHARMICA
Industry:
Medical Medical Device Pharmaceutical
Founded:
2001-01-01
Address:
Leeds, Leeds, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
+44 11 3384 6092
Similar Organizations
Digital Pharma Lab
Digital Pharma Lab is a discharge to assess digital acceleration program that focuses on manufacturing in the healthcare industry.
Haemato
Haemato is a pharmaceutical company that develops customized medical devices for healthcare sectors.
More informations about "Photopharmica"
Photopharmica - VentureRadar
Photopharmica was formed to develop light sensitive drugs for indications including oncology and infection. The company's technology uses small molecules that are activated by light, called โฆSee details»
Photopharmica - Products, Competitors, Financials, Employees ...
Photopharmica, developing light sensitive drugs for the prevention and treatment of diseases in the anti-infective and oncology markets photosensitisers, for industrial applications. Use the โฆSee details»
Photopharmica Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Photopharmica Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, and 1 literature, Drug:PPA-904, PPA-905.See details»
Photopharmica - Company Profile - Tracxn
Photopharmica - Developer of light-sensitive drugs for oncology and infection. Photopharmica has 2861 competitors.See details»
Photopharmica - Overview, News & Similar companies - ZoomInfo
Who is Photopharmica. Photopharmica was established in 2001 to develop novel photosensitisers as products for medical use. The Company has opened up new applications of topical โฆSee details»
Photopharmica Limited Company Profile, Financial and ... - digitGaps
Photopharmica Limited was founded in 2001 and is based in Leeds, United Kingdom. digitGaps report on Photopharmica Limited delivers a detailed in-depth and comprehensive insights of โฆSee details»
Photopharmica Ltd.:Company Profile & Technical โฆ
Photopharmica Ltd. is a company that provides Medical equipment, Phthalocyanine, Anti-Infective Agents and more. Photopharmica Ltd. is headquartered in United Kingdom LEEDS. โฆSee details»
Photopharmica - Crunchbase
Photopharmica is discovers and develops photo sensitizers and light sources for medical use in the United Kingdom.See details»
Organization | Photopharmica
Photopharmica Report issue. For profit Phase 2. Founded: Leeds United Kingdom ... Organization Overview. First Clinical Trial. 2009 NCT00825760. First Marketed Drug. None First NDA โฆSee details»
REF Case study search
Photopharmica has raised £11.5M in external investment, around £6.0M of which has been deployed since 2009 to support a 57 patient phase IIb clinical trial. The results, which showed โฆSee details»
PHOTOPHARMICA LIMITED overview - Find and update company โฆ
Jun 12, 2018 Filing history for PHOTOPHARMICA LIMITED (08315366) People for PHOTOPHARMICA LIMITED (08315366) More for PHOTOPHARMICA LIMITED (08315366) โฆSee details»
Photopharmica - Tech Stack, Apps, Patents & Trademarks
Organization. Photopharmica . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit Patents and โฆSee details»
ENLIGHTENED SOLUTIONS - Photopharmica Limited Trademark โฆ
Photopharmica Limited. USPTO Trademarks โบ Photopharmica Limited โบ Enlightened Solutions Application #77076953. Application Filed: 2007-01-05. Trademark Application Details. Status โฆSee details»
What is Photopharmica? Company Culture, Mission, Values
Photopharmica. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your โฆSee details»
PPA-904 - Drug Targets, Indications, Patents - Synapse - Patsnap
An initial regimen recommended by the manufacturer (Photopharmica Co. Ltd., Leeds, UK) was maintained as a control: the cream was applied topically for 30 minutes at a final concentration โฆSee details»
Photopharmica Ltd.:Funding,Funding Rounds,Funding Analysis
Discovery Company profile page for Photopharmica Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Photopharmica CEO, Founder, Key Executive Team, Board of โฆ
Explore {Photopharmica's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
PPA-905 - Drug Targets, Indications, Patents - Synapse
PPA-905, Initially developed by Photopharmica Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Skin and Musculoskeletal Diseases,Other Diseases. ... Originator โฆSee details»
Largest Phototherapy Trial for Parkinsonโs Disease
February 10, 2020, Salt Lake City, UTโ PhotoPharmics announced today plans to conduct a pivotal trial to assess the efficacy of Celeste®, the companyโs specialized phototherapy device โฆSee details»